USPTO trademark

AMLYPAVE

AllowedUSPTOWord markClass 5

"AMLYPAVE" is a word mark owned by Alexion Pharmaceuticals, Inc., filed at the USPTO on June 3, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View Alexion Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
AMLYPAVE trademark as filed
As filed with the USPTO
Status
Allowed
Since June 8, 2026
Filed
June 3, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99216119
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns AMLYPAVE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alexion Pharmaceuticals, Inc.

ALXN · Boston, United States

208 trademarks in the portfolioView company

Representative

Leonid Rakitin

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services AMLYPAVE is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Notice of approval of extension request e-mailed
  5. Sou extension 1 granted
  6. Sou extension 1 filed
  7. Sou teas extension received
  8. Noa e-mailed - sou required from applicant
  9. Official gazette publication confirmation e-mailed
  10. Published for opposition

6 earlier steps on the official record.

FAQ

About AMLYPAVE

Who owns the trademark "AMLYPAVE"?

The USPTO trademark "AMLYPAVE" (application 99216119) is owned by Alexion Pharmaceuticals, Inc.

What is the status of "AMLYPAVE"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AMLYPAVE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ad6-6ea9-763f-9f8c-ae198f976d3b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ad6-6ea9-763f-9f8c-ae198f976d3b",
  "object": "trademark",
  "mark_text": "AMLYPAVE",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99216119",
  "filing_date": "2025-06-03",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Alexion Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb70a-13c6-766b-b4ec-ed9ff6c116be"
    }
  ]
}